Stock & Company Details
ICU Medical, Inc. $ICUI
Price:
N/A
N/A
25M
$4.2B
52 Week High:
N/A
10 Day Average Volume:
N/A
91.07
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ICUI technical indicators
Latest ICU Medical, Inc. (ICUI) indicator readings as of 2026-10-29.
ICUI's 14-day RSI is 58.0, in neutral territory. At $168.65 it is trading 13.6% above its 200-day moving average of $148.52, and above its 50-day average of $164.60. Price sits near the upper Bollinger Band ($155.90 to $169.74). ADX reads 13.8, indicating a range-bound market rather than a trend.
Overview
ICU Medical is a California-based, pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017, and Smiths Medical from Smiths Group in 2022. It holds top-tier positions in its original reporting segments: infusion consumables (25% of 2022 revenue), IV solutions (16%), infusion systems (15%), and critical care (2%) as well as its new Smiths segments: Smiths infusion systems (15%), vascular access (14%), and vital care (12%). The combined entity remains primarily U.S. focused, generating over 64% of its sales domestically.
Finance Bot
Ask your questions
Start by typing a question below.
